Sodium Butyrate Induces Peri-Implantitis in Male Rats Via Caspase-3/ Gasdermin E Pathway Mediated Pyroptosis

Introduction Peri-implantitis is a plaque-associated inflammatory disease characterized by progressive bone loss around implants, yet its underlying molecular mechanisms remain incompletely understood. Although butyric acid, a microbial metabolite enriched in peri-implant lesions, has been implicated in inflammatory tissue destruction, whether it contributes to peri-implantitis through Caspase-3/GSDME-mediated pyroptosis remains unclear. Methods (1) Peri-implant sulcular fluid was collected from healthy implants and peri-implantitis patients. Butyric acid and IL-1β were measured via gas chromatography-mass spectrometry and enzyme-linked immunosorbent assay. (2) Male rats received weekly peri-implant injections of 100 mM sodium butyrate (NaB), with or without the Caspase-3 inhibitor Ac-DEVD-CHO. Inflammation, bone loss, and pyroptosis-related marker expression were evaluated. Results Butyric acid and IL-1β were elevated in peri-implantitis patients and showed a moderate positive correlation (r = 0.6815, P < .05). NaB induced peri-implant inflammation and bone loss as demonstrated by radiographic and histological analyses (BV/TV P < .001; BMD P < .01) with increased Caspase-3 and Gasdermin E (GSDME) expression (immunohistochemical and molecular biological analysis; P < .01). Ac-DEVD-CHO treatment significantly reduced inflammatory cell infiltration, suppressed the expression of pyroptosis-related and osteoclastogenic markers, and attenuated bone loss, as demonstrated by radiographic, histological, and molecular biological analyses. Conclusion NaB exposure was associated with increased Caspase-3/GSDME pathway activation, peri-implant inflammation and bone loss. Caspase-3 inhibition alleviated these pathological changes, supporting this pathway as a potential therapeutic target for peri-implantitis. Clinical relevance Targeting the Caspase-3/GSDME pathway could provide a potential approach for managing peri-implantitis by reducing inflammation and bone loss, offering a possible complement to current treatment strategies.

Authors

Institutions

Publication Details

Journal
International Dental Journal
Published
2026-11-19
DOI
https://doi.org/10.1016/j.identj.2026.111347
Primary Topic
Dental Implant Techniques and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sodium Butyrate Induces Peri-Implantitis in Male Rats Via Caspase-3/ Gasdermin E Pathway Mediated Pyroptosis

Muxin Yue, Zhixiao Wu, Fan Yang, Ying Chen et al.
International Dental Journal
Dental Implant Techniques and Outcomes
article

Sodium Butyrate Induces Peri-Implantitis in Male Rats Via Caspase-3/ Gasdermin E Pathway Mediated Pyroptosis

Muxin Yue, Zhixiao Wu, Fan Yang, Ying Chen, Qian Ding, Liang Shao, Dong Han, Lei Zhang
article en

Abstract

Introduction Peri-implantitis is a plaque-associated inflammatory disease characterized by progressive bone loss around implants, yet its underlying molecular mechanisms remain incompletely understood. Although butyric acid, a microbial metabolite enriched in peri-implant lesions, has been implicated in inflammatory tissue destruction, whether it contributes to peri-implantitis through Caspase-3/GSDME-mediated pyroptosis remains unclear. Methods (1) Peri-implant sulcular fluid was collected from healthy implants and peri-implantitis patients. Butyric acid and IL-1β were measured via gas chromatography-mass spectrometry and enzyme-linked immunosorbent assay. (2) Male rats received weekly peri-implant injections of 100 mM sodium butyrate (NaB), with or without the Caspase-3 inhibitor Ac-DEVD-CHO. Inflammation, bone loss, and pyroptosis-related marker expression were evaluated. Results Butyric acid and IL-1β were elevated in peri-implantitis patients and showed a moderate positive correlation (r = 0.6815, P < .05). NaB induced peri-implant inflammation and bone loss as demonstrated by radiographic and histological analyses (BV/TV P < .001; BMD P < .01) with increased Caspase-3 and Gasdermin E (GSDME) expression (immunohistochemical and molecular biological analysis; P < .01). Ac-DEVD-CHO treatment significantly reduced inflammatory cell infiltration, suppressed the expression of pyroptosis-related and osteoclastogenic markers, and attenuated bone loss, as demonstrated by radiographic, histological, and molecular biological analyses. Conclusion NaB exposure was associated with increased Caspase-3/GSDME pathway activation, peri-implant inflammation and bone loss. Caspase-3 inhibition alleviated these pathological changes, supporting this pathway as a potential therapeutic target for peri-implantitis. Clinical relevance Targeting the Caspase-3/GSDME pathway could provide a potential approach for managing peri-implantitis by reducing inflammation and bone loss, offering a possible complement to current treatment strategies.

International Dental JournalVol. 77(1)
Peking University (CN)
Dental Implant Techniques and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon